Abstract:Recent studies indicated that oligomeric β -amyloid (A β) peptides are more neurotoxic to cells or tissues than A β monomers and fibrils even though the underlying mechanism of the A β -induced toxicity is still elusive. The discovery of inhibitors that can prevent cytotoxic oligomeric A β formation has become one of vital goals for therapeutic drug development for AD. Meanwhile, it is of fundamental importance to investigate and understand the structure of toxic A β oligomeric assembly, the mechanism of the induced cytotoxicity, the inhibitory mode of action, and the structural-activity relationship of inhibiting amyloid oligomerization. Toward this end, a series of 15 novel cyanine-derived A β peptide aggregation inhibitors have been synthesized aiming at investigating the structural-activity properties of these compounds in the role of AD treatment. Fifteen novel carbazole-based cyanine derivatives bearing various functionalized heteroaromatic electron-accepting moieties including pyridinium, benzothiazolium, quinolinium and acridinium have been synthesized for a systematic structure-activity relationships investigation as useful and potent A β peptide aggregation inhibitors. The binding affinity was characterized by dissociation constants derived from fluorescence titration of cyanine compounds against amyloid full-length A β 1-40, A β 1-42 peptides as well as A β fragments of different regions. The inhibitory effect on A β peptide aggregation was investigated with fluorescence, and transmission electron microscopy, and circular dichroism. The bio-viability was evaluated by cell-based and animal studies. Our studies further affirmed the importance of hydrophobic and Ï€-Ï€ stacking interactions for the association of this class of carbazole-based cyanines with A β peptides and fibrils. Slight structural modification alters the binding affinity to the monomeric and aggregated amyloids and hence the inhibition potency. Fifteen newly designed cyanine derivatives for studying the structural/activity properties of the A β binding and A β aggregation inhibition have been developed. Importantly, such slight structural variation also provides a means to tune the biological properties such as cytotoxicity and protection from A β- induced toxicity for potential clinical applications. Remarkably, seven non-toxic cyanine derived inhibitors for A β peptide self-aggregation are identified which shows therapeutic potential for AD treatment.

Tetracycline Derivatives Resist the Assembly Behavior of Human Islet Amyloid Polypeptide

Cross-Seeding Interaction Between Β-Amyloid and Human Islet Amyloid Polypeptide.

Procyanidine Resists the Fibril Formation of Human Islet Amyloid Polypeptide.

Triterpenoids impede the fibrillation and cytotoxicity of human islet amyloid polypeptide

Exploration of Isoquinoline Alkaloids As Potential Inhibitors Against Human Islet Amyloid Polypeptide

Regulation Of Artemisinin And Its Derivatives On The Assembly Behavior And Cytotoxicity Of Amyloid Polypeptides Hiapp And A Beta

Inhibitor discovery targeting the intermediate structure of β-amyloid peptide on the conformational transition pathway: Implications in the aggregation mechanism of β-amyloid peptide

Stabilities and Structures of Islet Amyloid Polypeptide (IAPP22-28) Oligomers: from Dimer to 16-Mer.

Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.

-Carboline Alkaloids Resist the Aggregation and Cytotoxicity of Human Islet Amyloid Polypeptide

Assembly behavior of amylin fragment hIAPP19-37 regulated by Au(III) complexes

Regulation of the Aggregation Behavior of Human Islet Amyloid Polypeptide Fragment by Titanocene Complexes

Hydrophobic/Hydrophilic Ratio of Amphiphilic Helix Mimetics Determines the Effects on Islet Amyloid Polypeptide Aggregation

Tanshinones Inhibit Hiapp Aggregation, Disaggregate Preformed Hiapp Fibrils, and Protect Cultured Cells.

Regulation of oxaliplatin and carboplatin on the assembly behavior and cytotoxicity of human islet amyloid polypeptide

Tuning the rate of aggregation of hIAPP into amyloid using small-molecule modulators of assembly

Inhibition of human islet amyloid polypeptide or amylin aggregation by two manganese-salen derivatives

POTENT INHIBITORS FOR OLIGOMERIC B-AMYLOID AGGREGATION

Mechanism Study on the Abnormal Accumulation and Deposition of Islet Amyloid Polypeptide by Cold-Spray Ionization Mass Spectrometry.

Resistance of Nepetin and Its Analogs on the Fibril Formation of Human Islet Amyloid Polypeptide.

Molecular Dynamics Simulations Reveal The Inhibitory Mechanism Of Dopamine Against Human Islet Amyloid Polypeptide (Hiapp) Aggregation And Its Destabilization Effect On Hiapp Protofibrils